Harvard Bioscience HBIO Income Statement (2010-2026)

NASDAQ HBIO
$7.90 -0.14 (-1.77%)
As of: Sep 10, 2026 · 9:46 AM EDT
Reported Financials

Harvard Bioscience Quarterly Income Statement

Periods 65 quarters
Latest Jun 2026

Harvard Bioscience reported revenue of $22.73M and net income of -$2.91M for the quarter ended Jun 2026, up 11.1% year over year. This income statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
29.66M33.05M28.78M29.21M26.92M28.43M29.98M28.76M25.36M28.15M24.51M23.10M21.97M24.56M21.77M20.45M20.59M23.73M20.75M22.73M
Cost of RevenueCost of Rev
13.36M13.49M12.60M12.57M14.75M12.59M11.63M12.09M10.64M11.83M9.74M9.88M9.21M10.54M9.59M8.92M8.57M9.56M8.51M10.10M
Gross Profit
16.31M19.56M16.18M16.64M12.17M15.83M18.35M16.67M14.73M16.32M14.77M13.22M12.77M14.01M12.18M11.53M12.02M14.17M12.24M12.63M
Operating items
Amortization - Intangibles
1.50M1.44M1.50M1.50M1.60M1.62M1.39M1.39M1.36M1.39M1.33M1.33M1.33M1.26M1.16M1.16M0.85M0.85M0.82M0.82M
Research & DevelopmentR&D
6.18M7.34M6.69M6.59M5.82M5.95M5.98M6.18M5.73M6.17M5.90M5.39M5.52M5.39M4.97M4.54M4.61M5.09M5.33M5.40M
Selling, General & AdministrativeSG&A
5.46M6.12M6.33M5.98M6.32M5.86M6.33M5.35M5.81M5.26M5.96M5.69M5.04M4.80M5.18M4.26M4.18M4.12M4.70M4.62M
Restructuring CostsRestructuring
5.19M-4.88M-0.54M0.40M0.18M0.10M0.03M0.05M0.23M0.32M
Other Operating ExpensesOther Opex
4.12M4.40M4.69M4.95M4.33M4.48M4.29M4.35M4.12M4.61M5.18M3.81M3.90M3.80M51.60M3.52M2.99M3.25M3.15M3.27M
Operating ExpensesOpex
15.76M17.86M22.89M12.64M15.93M16.29M16.60M15.88M15.66M16.04M17.05M15.29M14.64M14.00M61.85M12.35M11.82M12.46M13.42M13.61M
Operating IncomeOp. Inc
0.55M1.70M-6.71M4.00M-3.76M-0.46M1.75M0.80M-0.93M0.28M-2.28M-2.07M-1.87M0.01M-49.67M-0.82M0.20M1.71M-1.17M-0.98M
EBIT
0.55M1.70M-6.71M4.00M-3.76M-0.46M1.75M0.80M-0.93M0.28M-2.28M-2.07M-1.87M0.01M-49.67M-0.82M0.20M1.71M-1.17M-0.98M
Non-operating items
Non Operating Interest Expenses
Non Operating Investment IncomeNon-Op. Investment Inc.
-1.58M1.21M-0.26M-1.31M-0.28M
Interest & Investment IncomeInt & Inv Inc
-0.37M-0.38M-0.38M-0.52M-0.75M-0.90M-0.97M-0.94M-0.88M-0.79M-0.75M-0.75M-0.86M-1.18M-0.93M-1.00M-0.97M-2.36M-1.73M-1.79M
Other Non Operating IncomeOther Non Op Inc.
-0.13M-0.19M0.08M-0.06M-0.18M0.47M0.43M-0.37M0.04M-0.33M-0.14M-0.18M-0.52M0.52M-0.19M-0.43M-0.36M-1.32M-0.41M-0.12M
Non Operating IncomeNon Op. Inc.
-0.50M-0.57M-0.31M-0.58M-0.93M-0.43M-0.54M-2.89M0.37M-1.39M-2.21M-1.21M-2.62M0.58M-1.13M-1.44M-1.33M-4.91M-2.13M-1.92M
Net income details
EBT
0.04M1.13M-7.02M3.42M-4.69M-0.89M1.21M-2.10M-0.56M-1.10M-4.48M-3.28M-4.49M0.59M-50.79M-2.25M-1.13M-3.20M-3.31M-2.90M
Tax ProvisionsTaxes
0.21M0.54M-0.14M1.00M-1.30M-1.49M0.60M-1.12M0.70M0.71M0.21M-0.40M0.31M-2.65M-0.50M0.03M0.10M-11.63M0.12M0.01M
Profit After TaxPAT
-0.17M0.96M-6.88M2.44M-3.40M-1.67M0.62M-0.98M-1.24M-1.82M-4.69M-2.93M-4.80M0.02M-50.34M-2.28M-1.23M-2.85M-3.42M-2.91M
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
-0.17M0.59M-6.88M2.42M-3.39M0.60M0.61M-0.98M-1.26M-1.82M-4.69M-2.88M-4.80M3.24M-50.29M-2.28M-1.23M8.43M-3.42M-2.91M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
-0.17M0.59M-6.88M2.42M-3.39M0.60M0.61M-0.98M-1.26M-1.82M-4.69M-2.88M-4.80M3.24M-50.29M-2.28M-1.23M8.43M-3.42M-2.91M
Income towards Parent CompanyParent Net Inc
-0.17M0.59M-6.88M2.42M-3.39M0.60M0.61M-0.98M-1.26M-1.82M-4.69M-2.88M-4.80M3.24M-50.29M-2.28M-1.23M8.43M-3.42M-2.91M
Net Income towards Common StockholdersNet Income
-0.17M0.59M-6.88M2.44M-3.40M0.60M0.61M-0.98M-1.24M-1.82M-4.69M-2.88M-4.80M3.24M-50.29M-2.28M-1.23M8.43M-3.42M-2.91M
Additional items
EPS (Basic)
-0.040.15-1.670.59-0.820.140.14-0.23-0.29-0.43-1.08-0.66-1.100.74-11.41-0.52-0.281.90-0.77-0.64
EPS (Diluted)
-0.040.15-1.670.57-0.820.140.14-0.23-0.29-0.43-1.08-0.66-1.100.74-11.41-0.52-0.281.90-0.77-0.64
Shares Outstanding
4.08M4.03M4.12M4.13M4.16M4.14M4.21M4.24M4.27M4.24M4.34M4.35M4.36M4.35M4.41M4.43M4.46M4.44M4.47M4.53M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
4.08M4.03M4.12M4.26M4.16M4.14M4.28M4.24M4.27M4.24M4.34M4.35M4.36M4.35M4.41M4.43M4.46M4.44M4.47M4.53M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
4.08M4.11M4.12M4.15M4.17M4.21M4.22M4.27M4.27M4.34M4.34M4.36M4.36M4.41M4.42M4.45M4.46M4.47M4.51M4.55M
EBITDA
0.55M1.70M-6.71M4.00M-3.76M-0.46M1.75M0.80M-0.93M0.28M-2.28M-2.07M-1.87M0.01M-49.67M-0.82M0.20M1.71M-1.17M-0.98M
Interest ExpensesInt Expense
Tax Rate
477.78%47.83%1.97%29.23%27.72%167.04%49.71%53.29%-124.56%-64.82%-4.68%12.20%-6.92%-449.15%0.98%-1.33%-8.82%363.11%-3.54%-0.48%